Zobrazeno 1 - 10
of 330
pro vyhledávání: '"Ting Chao Chou"'
Autor:
Shu-Fu Lin, Yi-Yin Lee, Ming-Hsien Wu, Yu-Ling Lu, Chun-Nan Yeh, Wei-Yi Chen, Ting-Chao Chou, Wong, Richard J.
Publikováno v:
Endocrine-Related Cancer; Dec2023, Vol. 30 Issue 12, p61-74, 14p
Autor:
Ting-chao Chou
Publikováno v:
ASPET 2023 Annual Meeting Abstract - Drug Discovery and Development.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83f8b8409619b057cd15fa941f42421c
https://doi.org/10.1124/jpet.122.185320
https://doi.org/10.1124/jpet.122.185320
Autor:
Alok K Choudhary, David Calianese, William Honnen, Afsal Kolloli, Ryan J Dikdan, Dabbu Jaijyan, Ge Song, Tazio Capozzola, Vikash Akkaraju, Arun Mattappallil, Anthony Rosania, Salman Khan, Mark Lerman, Nikaein Afzal, Selvakumar Subbian, Ting Chao Chou, Raiees Andrabi, Dennis Burton, Abraham Pinter
The increasing prevalence of the highly antibody-evasive Omicron sublineages increases the risk of breakthrough infections and leaves high-risk and vulnerable immunocompromised individuals with no effective options for prophylactic or therapeutic ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de6f74efadaba394c915b2d9fcc3b55b
https://doi.org/10.1101/2023.05.04.539267
https://doi.org/10.1101/2023.05.04.539267
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172315 (2017)
We explored the therapeutic effects of dinaciclib, a cyclin-dependent kinase (CDK) inhibitor, in the treatment of thyroid cancer.Seven cell lines originating from three pathologic types of thyroid cancer (papillary, follicular and anaplastic) were st
Externí odkaz:
https://doaj.org/article/03e14623e08c4d3b97bf176f2f596284
Autor:
Ting‐Chao Chou
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1181383d9176ace6122df5afef1d8d78
https://doi.org/10.1096/fasebj.2022.36.s1.r2801
https://doi.org/10.1096/fasebj.2022.36.s1.r2801
Autor:
Ting‐Chao Chou
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fb500d5241c4cb0c1f8cd0451965b4a
https://doi.org/10.1096/fasebj.2022.36.s1.r3430
https://doi.org/10.1096/fasebj.2022.36.s1.r3430
Autor:
Ting‐Chao Chou
Publikováno v:
The FASEB Journal. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a23a0e6ab2adc3a9b6ea0f050608fe0e
https://doi.org/10.1096/fasebj.2022.36.s1.0r290
https://doi.org/10.1096/fasebj.2022.36.s1.0r290
Autor:
Ting-Chao Chou
Publikováno v:
Journal of Biological Chemistry. 299:103419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a91d4745e86ae5f2c393fd2dd6536de
https://doi.org/10.1016/j.jbc.2023.103419
https://doi.org/10.1016/j.jbc.2023.103419
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3487, p 3487 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3487, p 3487 (2021)
Simple Summary Adavosertib is a first-in-class Wee1 inhibitor that has demonstrated activity against certain cancers. We evaluated the effects of adavosertib in treating differentiated thyroid cancer (DTC) using four DTC cell lines (BHP7-13, K1, FTC-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a094ae7d73f45df318285fb935c5d944
Publikováno v:
Endocr Relat Cancer
Polo-like kinases (PLKs) are pivotal regulators of cell proliferation and cell survival; therefore, PLKs may be potential targets in the treatment of malignancy. The therapeutic effects of volasertib, a PLKs inhibitor for papillary and follicular thy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c4be00e2fc315c52ce570f13fe74ba
https://doi.org/10.1530/erc-18-0555
https://doi.org/10.1530/erc-18-0555